-
The Instruction of Nisoldipine
Time of Update: 2023-05-07
The Use of Nisoldipine in the Chemical Industry: An OverviewNisoldipine is a calcium channel blocker medication that is primarily used to treat high blood pressure and angina (chest pain).
When added to coatings and adhesives formulations, nisoldipine helps to improve their physical and mechanical properties, such as hardness and peel strength.
-
Domestic pharmaceutical companies compete for the blue ocean of the innovative drug market, and multiple tracks will become the focus of competition
Time of Update: 2023-02-01
In the future, under the continuous layout of enterprises, more new breakthroughs are expected in the field of innovative traditional Chinese medicine.
In the future, under the continuous layout of enterprises, more new breakthroughs are expected in the field of innovative traditional Chinese medicine.
-
The competition in the pharmaceutical industry has intensified, and pharmaceutical companies are accelerating the divestment of some businesses
Time of Update: 2022-05-16
On April 1, the multinational pharmaceutical company Daiichi Sankyo also announced that it will sign an equity transfer agreement with Chongqing Yaoyou Pharmaceutical, a subsidiary of Fosun Pharma, to transfer the production and sales rights of Colibidone tablets and Colibiduo injections in mainland China.
-
The 60th (Spring) Pharmaceutical Machinery Exhibition: Mettler invites you to discuss solutions for the pharmaceutical industry
Time of Update: 2022-05-06
Permission management Helps pharmaceutical production comply with regulatory requirements such as GMP METTLER TOLEDO provides industrial industrial weighing solutions ideal for pharmaceutical and biopharmaceutical environments Compliance with regulations, control of risks, and quality assurance: High-resolution weighing platform Hygienic Designed Weigh Modules Hygienically Designed Terminals Force sensors, in-line sensors and transmitters for process development, production and equipment maintenance personnel .
-
Synthetic lethal FIC encounters ineffective blockbuster drug IP will be besieged
Time of Update: 2022-05-03
To sum up, the reason that the petitioner based on evidence 2 that claim 1 cannot be supported by the description cannot be established;The problem of inventive step, the solvent described in paragraph [0040] of the patent specification involved by the patentee and the crystallization method described in counter-evidence 1 to obtain olaparib solvate are not enough to prevent those skilled in the art from not using other methods and other methods.
-
The field of children's medicine is attracting major pharmaceutical companies to accelerate their deployment
Time of Update: 2022-01-25
For another example, in the field of drugs that are clinically scarce for children with rare diseases in China, on December 17, 2021, Sunflower Pharmaceuticals and Dr.
, certain support from policy and economic levels has been given, which has increased the confidence of enterprises in R&D and production of children's medicines .
-
Sci-tech Innovation Board IPO supervision is tightening, and another pharmaceutical company goes public
Time of Update: 2022-01-10
In the first round of inquiries on the Sci-tech Innovation Board, the Shanghai Stock Exchange mainly focused on Heze Pharmaceutical’s technical services, technological achievement transformation, market position, revenue composition, R&D activities and R&D investment, and operating costs.
-
The pharmaceutical equipment market will continue to grow in the future. How can companies seize the opportunity
Time of Update: 2022-01-02
In recent years, it can be seen that pharmaceutical machinery companies including Chutian and Tofflon have paid more attention to talent training, recruiting talents through various methods such as cooperation with schools and enterprises, and improving salaries; on the other hand, industry construction is also needed.
-
Ascent Pharmaceuticals APG-115 for the treatment of stage IIB-IV melanoma was approved as an orphan drug by the FDA
Time of Update: 2021-07-27
However, due to the particularity of the MDM2-p53 protein interaction, it has brought considerable difficulties to the development of small molecule inhibitors, leading to a handful of drugs under research in this field in the world .
-
An antithrombotic drug that has skyrocketed by 195%, the Hunan pharmaceutical company has been approved
Time of Update: 2021-04-23
Medical Network, April 20, April 15, NMPA official website data shows that Hunan Qianjin Xiangjiang Pharmaceutical's application for the 4 types of imitation of Apixaban tablets was approved and deemed to have been reviewed.
-
In 2021, multinational pharmaceutical companies begin to accelerate the adjustment of their business models
Time of Update: 2021-04-20
6667px;text-align:justify;white-space:normal;'>In fact, under the influence of centralized domestic procurement, many multinational pharmaceutical companies are accelerating the adjustment of their business models by focusing on core market promotion, optimizing product lines, and laying off employees.
-
Demand gap large Huaren pharmaceutical companies began to plan the production of molten spray
Time of Update: 2021-03-06
According to china's industrial textile industry association statistics, as of April this year, the daily production capacity of domestic melt-sprayed non-wovens in about 200 tons (1 ton of molten non-wovens can produce 1 million masks or 300,000 N95 masks).
-
Drug Mingkangde 13 board market value of more than 100 billion
Time of Update: 2021-02-28
Drug Mingkangde 24 again rose and stopped, the stock has been 13 consecutive days of ups and downs (including the first day of 44% rise), as of the release, the stock did not open the rise and stop, a
-
Under the trend of innovation, the number of clinical trials in China has soared
Time of Update: 2020-11-17
Innovating, the number of clinical trials in China has soared (Photo: Pharmaceutical Network) In this trend, with the reform of China's new drug review and approval and the accelerated global market of new drugs, participation in global drug clinical trials has increasingly become an important work of Chinese pharmaceutical companies.
-
A large number of provinces announced the third batch of national mining network, the drug market is about to change
Time of Update: 2020-11-15
"Pharmaceutical Network Industry Dynamics" In early August, the third batch of national organizations centralized procurement of drugs related documents issued, procurement involving a total of 56 dr
